Kura Oncology, Inc. (KURA)
7.77
+0.34
(+4.58%)
USD |
NASDAQ |
Nov 13, 16:00
7.88
+0.11
(+1.42%)
After-Hours: 19:59
Kura Oncology Total Liabilities (Quarterly) : 548.54M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 548.54M |
| June 30, 2026 | 539.36M |
| March 31, 2026 | 544.67M |
| December 31, 2025 | 564.23M |
| September 30, 2025 | 406.84M |
| June 30, 2025 | 376.94M |
| March 31, 2025 | 379.36M |
| December 31, 2024 | 627.04M |
| September 30, 2024 | 55.07M |
| June 30, 2024 | 49.05M |
| March 31, 2024 | 48.82M |
| December 31, 2023 | 51.66M |
| September 30, 2023 | 43.83M |
| June 30, 2023 | 35.06M |
| March 31, 2023 | 30.79M |
| December 31, 2022 | 36.03M |
| September 30, 2022 | 28.37M |
| June 30, 2022 | 21.93M |
| March 31, 2022 | 22.34M |
| December 31, 2021 | 27.44M |
| September 30, 2021 | 27.38M |
| June 30, 2021 | 26.34M |
| March 31, 2021 | 34.28M |
| December 31, 2020 | 36.31M |
| Date | Value |
|---|---|
| September 30, 2020 | 33.07M |
| June 30, 2020 | 30.63M |
| March 31, 2020 | 23.26M |
| December 31, 2019 | 23.19M |
| September 30, 2019 | 21.02M |
| June 30, 2019 | 19.10M |
| March 31, 2019 | 20.05M |
| December 31, 2018 | 21.39M |
| September 30, 2018 | 16.89M |
| June 30, 2018 | 17.23M |
| March 31, 2018 | 16.66M |
| December 31, 2017 | 15.99M |
| September 30, 2017 | 13.92M |
| June 30, 2017 | 12.21M |
| March 31, 2017 | 11.68M |
| December 31, 2016 | 12.94M |
| September 30, 2016 | 12.64M |
| June 30, 2016 | 11.70M |
| March 31, 2016 | 4.316M |
| December 31, 2015 | 5.156M |
| September 30, 2015 | 5.043M |
| June 30, 2015 | 4.208M |
| March 31, 2015 | 5.922M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 94.06M |
| Capricor Therapeutics, Inc. | 120.61M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 566.50M |
| Shareholders Equity (Quarterly) | 17.96M |
| Debt to Equity Ratio | 1.438 |
| Current Ratio | 3.595 |
| Net Debt Paydown Yield | -0.13% |